Highlights Abbott Laboratories Swiss Exchange

Stocks

ABT

US0028241000

Medical Equipment, Supplies & Distribution

Market Closed - Swiss Exchange Other stock markets 11:35:47 2026-07-30 EDT			5-day change	1st Jan Change
85.00 ^CHF	-3.41%		+0.59%	-14.14%

07-31	Amgen discloses data breach involving patient health information	RE
07-30	Dexcom raises annual revenue forecast on strong demand for glucose monitors	RE

Highlights

07-28	Tranche Update on Abbott Laboratories's Equity Buyback Plan announced on October 16, 2024.	CI
07-24	Abbott defeats shareholder lawsuit over 2022 infant formula recall	RE
07-24	Abbott wins dismissal of shareholder lawsuit over 2022 infant formula recall	RE
07-17	Abbott investigates two separate cyber incidents, says no operations affected	RE
07-17	Abbott Laboratories Seen on Track for H2 Growth Acceleration, RBC Says	MT
07-16	Abbott Laboratories Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
07-16	Abbott Laboratories Raises Full-Year Earnings Guidance as Second-Quarter Results Top Views	MT
07-16	Abbott Laboratories 2Q Sales Rise on Diagnostics Growth	DJ
07-16	Abbott raises its 2026 adjusted EPS target range
07-16	Abbott Laboratories Q2 Adjusted Earnings, Revenue Rise; Raises 2026 Earnings Guidance	MT
07-16	(ABT) Abbott Laboratories Expects Q3 Adjusted EPS Range $1.38 - $1.46	MT
07-16	(ABT) Abbott Laboratories Expects 2026 Adjusted EPS Range $5.45 to $5.60, vs. FactSet Est of $5.47	MT
07-16	Earnings Flash (ABT) Abbott Laboratories Reports Q2 Revenue $12.59B, vs. FactSet Est of $12.52B	MT
07-16	Earnings Flash (ABT) Abbott Laboratories Posts Q2 Adjusted EPS $1.31 per Share	MT
07-02	Missouri jury sides with Enfamil maker Mead Johnson in case over preterm baby formula	RE
06-29	PRESS DIGEST-Wall Street Journal - June 29	RE
06-28	US DOJ closes criminal probe into Abbott over baby formula plant, WSJ reports	RE
06-24	Abbott Laboratories, ALZpath Sign Global Licensing Deal for Alzheimer's Disease Diagnostic	MT
06-12	Abbott Laboratories Keeps Quarterly Dividend at $0.63 a Share, Payable Aug. 17 to Holders of Record as of July 15	MT
06-12	Abbott Laboratories Declares Quarterly Cash Dividend, Payable on August 17, 2026	CI
06-06	Abbott Announces Dual Glucose-Ketone Sensing Technology with Libre Duo and Libre Duo 10 Day Systems	CI
06-04	Abbott Labs must face lawsuit over PediaSure children's growth claims	RE
05-27	Abbott Highlights Cologuard And Cologuard Plus As Preferred Noninvasive Colorectal Cancer Screening Options In Updated American Cancer Society Guideline	CI
04-29	Tranche Update on Abbott Laboratories's Equity Buyback Plan announced on October 16, 2024.	CI
04-28	Abbott Receives Fda Clearance for Next-Generation Ultreon 3.0 Ai-Powered Coronary Imaging Platform	CI